… in the atherosclerosis-related inflammation. Interleukin (IL)-15 is a pleiotropic cytokine that
… a sample of the Mexican population with subclinical atherosclerosis (CAC > 0) because …

… This, in turn, will exacerbate atherosclerosis. Statins suppress the activation of MCs via IgE
… and cytokines which are involved in the development and progression of atherosclerosis. …

Atherosclerosis (AS) is the most common factor causing many cardiovascular and cerebrovascular
diseases and has received considerable attention. The occurrence mechanism of AS …

… cytokines to suppress local inflammation. The synergistic effects of pharmacotherapy and
inflammatory cytokines … lead to improved therapeutic efficacy in atherosclerosis. Comparison to …

… The initial event in the development of atherosclerosis is endothelial injury. This causes …
with foam cells, release a variety of cytokines that promote inflammation and ROS generation. …

Atherosclerosis is considered a chronic inflammatory … We here investigated the function of
FXII in atherosclerosis using … reduced expression of pro-inflammatory cytokines in the aorta in …

… The impact of IL-37 on inflammatory cytokines mediating atherosclerosis is beneficial and
protective. However, more studies are needed to better define this mechanism and the safety …

… Plaque macrophages express proinflammatory cytokines which have … atherosclerosis-prone
mice have been essential in establishing the crucial role of macrophage-derived cytokines …

… cytokines and other proinflammatory mediators, which strengthen the inflammatory properties
of phagocytes and ECs. In atherosclerosis… B lymphocytes in atherosclerosis on the basis of …

… Chemokines, a family of chemoattractant cytokines, are stored in alpha granules in platelets.
However, the production of cytokines and other mediators, eg IL-1β take place in the cytosol…